Antibiotic Prescription for Pediatric Urinary Tract Infection
For this 12.25-kg child with a urinary tract infection, prescribe oral trimethoprim-sulfamethoxazole (TMP/SMX) 24.5 mg trimethoprim + 122.5 mg sulfamethoxazole twice daily for 5 days, or oral cefixime 122.5 mg once daily for 5 days if local resistance rates permit. 1, 2
Primary Oral Regimen
For a child weighing 12.25 kg with UTI:
TMP/SMX (co-trimoxazole): 4 mg/kg/day trimethoprim component divided twice daily
Alternative first-line oral options (if TMP/SMX resistance >20% locally):
For Sulfa Allergy
If the child has a sulfa allergy, prescribe oral cefixime 122.5 mg once daily for 5 days, or oral amoxicillin-clavulanate 367.5 mg (amoxicillin component) twice daily for 5 days. 1, 2
Specific alternatives for sulfa allergy:
- Cefixime: 10 mg/kg/day = 122.5 mg once daily
- Amoxicillin-clavulanate: 30 mg/kg/day (amoxicillin component) divided twice daily = 183.75 mg twice daily (use 200 mg twice daily for practical dosing)
- Cefpodoxime: 10 mg/kg/day divided twice daily = 61 mg twice daily
For Inability to Take Oral Medication
If the child cannot take oral medication, prescribe parenteral ceftriaxone 612.5 mg (50 mg/kg) once daily IV/IM until oral intake is possible, then transition to oral therapy to complete 5-7 days total. 1, 2
Parenteral options when oral route unavailable:
Ceftriaxone: 50-80 mg/kg/day once daily IV/IM
- Dose: 612.5 mg once daily (can round to 600 mg for practical administration)
- Preferred for outpatient parenteral therapy 1
- Transition to oral therapy after clinical improvement (typically 24-48 hours)
Alternative parenteral regimen:
- Ampicillin 50 mg/kg every 6 hours IV PLUS Gentamicin 5-7.5 mg/kg once daily IV 1
- This combination covers broader spectrum but requires hospitalization for gentamicin monitoring
Clinical Decision Algorithm
Step 1: Assess Severity
- Uncomplicated cystitis (dysuria, frequency, no fever): Oral therapy for 5 days
- Febrile UTI/pyelonephritis (fever >38°C, flank pain): Consider parenteral therapy initially, then oral step-down for 7-10 days total 2, 3
Step 2: Check Local Resistance Patterns
- If E. coli TMP/SMX resistance <20%: Use TMP/SMX as first-line
- If resistance >20%: Use cephalosporin (cefixime, cefpodoxime) 2
Step 3: Determine Route
- Oral preferred for uncomplicated cystitis and mild pyelonephritis in well-appearing children 3
- Parenteral initially if: age <3 months, toxic appearance, vomiting/unable to tolerate oral, suspected urosepsis 4, 5
Step 4: Duration
- Uncomplicated cystitis: 5 days 2, 3
- Febrile UTI/pyelonephritis: 7-10 days total (may start IV then transition to oral) 2, 3
Important Caveats
Avoid these common errors:
Nitrofurantoin is NOT appropriate for febrile UTI or pyelonephritis—it achieves inadequate tissue concentrations outside the bladder 2, 6
Oral fosfomycin lacks pediatric data and should not be used in children 2, 6
Fluoroquinolones (ciprofloxacin, levofloxacin) should be reserved for multidrug-resistant organisms only due to musculoskeletal toxicity concerns in children 2
Amoxicillin monotherapy is inadequate due to high E. coli resistance rates (>40% in most regions) 5
Dosing errors are common with amoxicillin-clavulanate suspensions—always dose based on the amoxicillin component and verify concentration 7
Special Populations
For neonates (<28 days): Hospitalization required with ampicillin 50 mg/kg every 6 hours IV PLUS gentamicin 5-7.5 mg/kg once daily IV for 14 days total; must exclude meningitis with lumbar puncture 4
For infants 1-3 months: May use outpatient ceftriaxone 50 mg/kg once daily IM/IV until afebrile 24 hours, then oral step-down to complete 10-14 days 8, 4
For known vesicoureteral reflux: Same treatment duration; prophylaxis NOT routinely indicated after first UTI 9, 3
The evidence strongly supports shorter courses (5 days) for uncomplicated cystitis and early IV-to-oral transition for pyelonephritis, which reduces unnecessary antibiotic exposure without compromising outcomes 2, 3. Local antibiograms should guide empiric selection, but TMP/SMX and oral cephalosporins remain first-line agents where resistance permits.